CUMS -induces a loss of synaptic plasticity, decreased neurogenesis, and increased microglial activation, LPS - induces depression behaviors through chronic neuroinflammation and mitochondrial damage, 5-HTT - Loss of function, 5-HT1A - Loss of function
Major Depressive Disorder
Genotype
Chronic Unpredictable Mild Stress, Lipopolysaccharide (LPS)-Induced , Serotonin Transporter Knockout, 5-HT1A Receptor Knockout
Mechanism
CUMS -induces a loss of synaptic plasticity, decreased neurogenesis, and increased microglial activation, LPS - induces depression behaviors through chronic neuroinflammation and mitochondrial damage, 5-HTT - Loss of function, 5-HT1A - Loss of function
Phenotype
Depression, Anxiety, Anhedonia, Social isolation, Immobility, Cognitive impairment, Fatigue, Sleep disorder
Biomarker
Serotonin (5-HT), Dopamine (DA), Norepinephrine Cortisol, Leptin, Ghrelin, Insulin resistance
Gene Expression Markers
SLC6A4, HTR1A, TNF-α, IL-6, CRH, NR3C1, Bax, Bcl-2
Physiology Changes
EEG - Theta and Beta activity, Sleep - Reduced REM
Histology Grading Endpoint
Neuronal shrinkage, Astrocyte activation, White matter disruption



